Comprehensive Biomarker Testing for Lung Cancer
You do not need to be a doctor to understand your tumor. Biomarker testing can help. When your doctors suspected you had cancer, they took a small portion of your […]
Search Results for: molecular testing
FDA approves alectinib for ALK+ NSCLC
The good news The FDA recently approved alectinib as adjuvant treatment for patients after surgical removal of early stage (IB-IIIA) anaplastic lymphoma kinase – positive (ALK+) non-small cell lung cancer […]
Remembering Dann
Staying steady nearly two decades with stage 4 lung cancer
FDA approves repotrectinib for patients with advanced ROS-1 fusion non-small cell lung cancer
The good newsThe US Food and Drug Administration (FDA) approved repotrectinib (AugtyroTM) for the treatment of patients with advanced ROS-1 fusion non-small cell lung cancer (NSCLC) in November of 2023. […]
IASLC World Conference on Lung Cancer Recap
By Eugene Manley, Jr., PhDDirector, Scientific Programs, LCRF The International Association for the Study of Lung Cancer (IASLC) 2021 World Conference on Lung Cancer (WCLC 2021) took place September 8-14, […]
COVID-19 and Lung Cancer | Previous Statements
For further information: GO2 Foundation for Lung Cancer, Amy Moore, PhD | LUNGevity Foundation, Upal Basu Roy, PhD, MPH | Lung Cancer Foundation of America, Kim Norris | Lung Cancer […]
Previous studies
Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs Begun in 2008, the first LCMC study was a multi-institutional program for investigating the frequency of selected […]
Current funded projects
Each year, LCRF awards research grants to around the world that demonstrate promise and ingenuity in their work. These investigators, selected from hundreds of applicants, represent some of the brightest […]
Types of cancer treatment
It is important to note that treatment options may vary depending on the type of healthcare system you choose. Not all community hospitals and cancer centers may have the same […]
LCRF creates Scientific Executive Committee
Committee to guide foundation’s research program NEW YORK, NY (July 11, 2022) – The Lung Cancer Research Foundation (LCRF) is pleased to announce the appointment of a select group of […]